A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia
Clinical trial NCT04009577 · COMPLETED
Trial details
- NCT number
- NCT04009577
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2020-03-17
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.